Eko Health Gains FDA Clearance For Cardiology Algorithm That Can Detect Heart Failure in 15 Seconds
Eko Health received FDA clearance this week for a new AI-powered tool that aids in the early detection of low ejection fraction, a key indicator of heart failure. About 6.2 million Americans battle heart failure, with many of them experiencing low ejection fraction, a condition that occurs when the heart muscle pumps out less blood than normal during each contraction. Conventional methods for detecting reduced ejection fraction, such as echocardiography, are often unavailable in primary care settings because they are expensive and necessitate specialized training.
